FOCUS Program (Frontlines of Communities in the United States)

The FOCUS Program (Frontlines of Communities in the United States) is a grant initiative from Gilead Sciences that funds community-based research and programs addressing blood-borne virus prevention and treatment, particularly HIV and hepatitis C, in underserved U.S. communities.

The program supports community-based participatory research, prevention education, access to care, and initiatives advancing health equity for disproportionately affected populations. Eligible applicants include universities, academic medical centers, hospitals, and nonprofit service organizations. Award amounts vary based on project scope; contact Gilead Sciences for current application cycles and funding details.

Gilead Sciences: FOCUS Blood-Borne Virus Public Health Program Neglected & Emerging Viruses and Pandemic Preparedness Research Funding Programs Research Funding Programs Research Scholars Program External-Sponsored Research External-Sponsored Research Virology RFP Opportunities Oncology RFP Opportunities Inflammation RFP Opportunities Community-Based Participatory Research Diversity in Clinical Trials ESG Frameworks and Reporting Sustainability Focus Areas Asia Pacific Rainbow Grant Setting the P.

A. C. E.

- Prevention, Arts and Advocacy, Community, Education Toward Health Equity for Black People Impacted by TNBC Zeroing In: Ending the HIV Epidemic Giving in Europe & the Middle East Giving in Latin America & the Caribbean Building Community Donations Access in Low- and Middle-Income Countries Access in Low- and Middle-Income Countries Access Strategy for Long-Acting PrEP Invasive Fungal Infections Jacqueline K. Barton, PhD Jeffrey A.

Bluestone, PhD Board Governance and Committees U.S. Public Policy Engagement U.S. Public Policy Engagement Political Contributions Archives Supplier Enablement Resources: SAP Ariba Inclusion and Diversity in Hiring Early Career Opportunities Early Career Opportunities Gilead Internship Program Transforming Health Systems to Create Health Equity FOCUS advances healthcare systems transformation by supporting access to screening and linkage to comprehensive prevention services and linkage to care for HIV, hepatitis C (HCV) and hepatitis B (HBV).

Through FOCUS, we’ve partnered with hundreds of healthcare institutions over time to advance systems transformation and support FOCUS partner development and sharing of best practices for routine screenings, testing and diagnosis across HIV, HCV and HBV in accordance with public health guidelines in underserved communities to address health inequities.

In the U.S., the FOCUS program is a public health initiative that enables partners to develop and share best practices in routine blood-borne virus (HIV, HCV, HBV) screening, diagnosis and linkage to care in accordance with screening guidelines promulgated by the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Preventive Services Task Force (USPSTF), and state and local public health departments.

In Spain and Portugal, the FOCUS program is a public health initiative that enables partners to develop and share best practices in routine blood-borne virus (HIV, HCV, HBV) screening, diagnosis and linkage to care in accordance with screening guidelines promulgated by country guidelines and initiatives such as Fast-Track Cities. FOCUS funding supports HIV, HCV and HBV screening and linkage to a first appointment.

FOCUS partners do not use FOCUS awards for activities beyond linkage to a first appointment. FOCUS on Louisiana: Tackling Health Inequities Through Routine HIV and Viral Hepatitis Screening and Linkage to Care Implementation of the FOCUS model by partners in Louisiana has helped to support routine HIV and HCV testing across the state for eligible individuals.

FOCUS in Florida: Ending Multiple Public Health Epidemics with Public-Private Partnerships The Florida Department of Health has adopted a syndemic approach to HIV and HCV in collaboration with FOCUS. State leaders are incorporating the FOCUS model to help end these public health epidemics and included objectives to scale and sustain the FOCUS model in public health planning to help the hardest hit areas of the state.

Hospital and state leaders speak at a Tampa General Hospital press conference. The biennial FOCUS Partner Summit gathers partners, nationally recognized researchers, clinicians, government officials, public health leaders and Gilead leaders across the U.S. to share best practices in HIV and viral hepatitis screening, diagnosis and linkage to care.

Through the Partner Summit, FOCUS is enabled to continue to improve health equity and help partners expand access to routine screening and linkage to care in accordance with public health guidelines. An Evidence-Based Approach FOCUS supports partners to develop and share best practices in blood-borne virus screening, diagnosis and linkage to care — improving public health systems and how they serve communities.

Many published best practices and institutional policy changes have emerged through the work of FOCUS partners.

They've had over 1,850 abstracts accepted to key conferences, such as the Conference on Retroviruses and Opportunistic Infections (CROI), International AIDS Conference (IAS) and the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting, and have published over 225 articles in peer-reviewed journals, including three articles in CDC’s Morbidity and Mortality Weekly Report (MMWR).

This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit our Global Operations page for links to our international corporate websites.

Modern Slavery Act Statement